Antibiotic Resistance Market Anticipates Exponential Growth to USD 14.29 Billion By 2032

Report Overview

The antibiotic resistance market encompasses a broad spectrum of pharmaceuticals, diagnostics, and research aimed at addressing the global challenge of microbial resistance to antibiotics. Antibiotic resistance occurs when bacteria evolve mechanisms to withstand the effects of antibiotics, rendering these drugs ineffective against infections. This phenomenon poses a significant threat to public health, leading to prolonged illnesses, increased healthcare costs, and higher mortality rates.

Global Antibiotic Resistance Market size and share is currently valued at USD USD 9.18 billion in 2024 and is anticipated to generate an estimated revenue of USD 14.29 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032

Get a Sample with the Latest Trends and Future Advancements @ https://www.polarismarketresearch.com/industry-analysis/antibiotic-resistance-market/request-for-sample

The rising proliferation of inappropriate use of antibiotics, such as over-prescription, consumption with proper medical supervision, and incomplete or improper treatment courses, all result in the development of antibiotic-resistant strains, driving the global market growth. Also, the growing need for the discovery of new antibiotics with the ability to effectively combat several antibiotic-resistant strains and R&D efforts focused on new drug classes are also likely to bode well for the market's growth. For instance, in January 2023, Alkem Laboratories announced the launch of a new antibiotic drug for the treatment of multiple drug-resistant infections. This is a novel amalgamation of ceftazidime and avibactam, which is indicated for several ailments, including complicated urinary tract infections.

As whole-genome sequencing of the antimicrobial-resistant is being widely used for antimicrobial resistance surveillance, thereby, innovations in genome sequencing and different analysis technologies could revolutionize antibiotic resistance surveillance and epidemiology.

Furthermore, there is a growing focus on research and development activities or efforts to develop or discover new antibiotics, and various government authorities and health organizations are focusing on the methods to enhance antibiotic capabilities. Also, regulatory authorities are constantly working on raising awareness among the global population about antibiotic resistance and its health effects, which are likely to impact the market positively. For instance, in October 2023, The Quadripartite announced the creation of a new Working Group on Youth Engagement, especially for antimicrobial resistance. The members of the group will notify as well as guide quadripartite efforts to raise awareness and bring the younger population into the global AMR action.

Some of the major players operating in the global market include:

Achaogen Inc. (US)
BioVersys AG (Ireland)
CARB-X (US)
Destiny Pharma (UK)
F. Hoffmann-La Roche Ltd. (Switzerland)
Johnson & Johnson Services (US)
Melinta Therapeutics LLC (US)
Merck & Co. Inc. (Germany)
Nabriva Therapeutics Plc (Ireland)
Novartis AG (Switzerland)
Pfizer Inc. (US)
The Medicines Company (US)
Vertex Pharmaceuticals Incorporated (US)
West Way Health (Ireland)

Interested in personalized insights? Ask Us For Customization @ https://www.polarismarketresearch.com/industry-analysis/antibiotic-resistance-market/request-for-customization

Growth Drivers:

Rising Incidence of Antibiotic-Resistant Infections: The increasing prevalence of infections caused by antibiotic-resistant bacteria is a primary driver of market growth. Bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Enterobacteriaceae (CRE), and multi-drug resistant tuberculosis (MDR-TB) are of particular concern.

Growing Global Population: With a larger global population, there's a higher probability of infections, leading to increased demand for antibiotics and related therapies.

Technological Advancements: Advances in diagnostic techniques, such as molecular diagnostics and next-generation sequencing, have improved the identification and characterization of antibiotic-resistant strains. This aids in the development of targeted treatment strategies.

Applications:

Antibiotic Development: Pharmaceutical companies are actively engaged in developing new antibiotics and modifying existing ones to overcome resistance mechanisms. This includes the development of combination therapies, novel drug delivery systems, and antibiotics with different mechanisms of action.

Diagnostics: Rapid and accurate diagnostic tests are crucial for identifying antibiotic-resistant infections and guiding appropriate treatment decisions. Molecular diagnostic techniques, such as polymerase chain reaction (PCR) and sequencing, enable the detection of specific genetic markers associated with antibiotic resistance.

Infection Control: In healthcare settings, infection control measures are essential for preventing the spread of antibiotic-resistant bacteria. This includes strict adherence to hand hygiene protocols, environmental cleaning, and the implementation of antimicrobial stewardship programs to optimize antibiotic use.

Antibiotic Resistance Market Report Highlights

Complicated urinary tract infections segment accounted for significant share in 2023, on account of growing incidences of UTIs (urinary tract infections) globally
Oxazolidinones segment held the majority share in 2023, that is attributed to its greater efficacy and effectiveness against numerous drug-resistant bacteria or pathogens
Online pharmacies segment dominated the market in 2023, due to rising number of patients opting for remote consultation and popularity of e-prescriptions and digital health records
North America dominated the global market, owing to rising incidences of infectious diseases and development of new antibiotic solutions

Purchase the Report for Key Insights @ https://www.polarismarketresearch.com/buy/3312/2

Polaris Market Research has segmented the antibiotic resistance market report based on disease, drug type, distribution channel, and region:

Antibiotic Resistance, Disease Outlook (Revenue - USD Billion, 2023 - 2032)

cUTI (Complicated Urinary Tract Infections)
CDI (Clostridioides Difficile Infection)
ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
HABP (Hospital-acquired Bacterial Pneumonia)
CABP (Community-acquired Pneumonia)
cIAI (Complicated Intra-abdominal Infection)
BSI (Bloodstream Infection)

Antibiotic Resistance, Drug Class Outlook (Revenue - USD Billion, 2023 - 2032)

Oxazolidinones
Lipoglycopeptides
Tetracyclines
Combination Therapies
Cephalosporins
Others

Antibiotic Resistance, Distribution Channel Outlook (Revenue - USD Billion, 2023 - 2032)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Antibiotic Resistance, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Contact Us:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

About Us:

Polaris Market Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

This release was published on openPR.